台股 » 佳醫 » 個股財報 » 每月營收

佳醫

(4104)
可現股當沖
  • 股價
    96.2
  • 漲跌
    ▼0.2
  • 漲幅
    -0.21%
  • 成交量
    203
  • 產業
    上市 生技醫療類股 ▲0.04%
  • 本地時間:14:30(已收盤)

    325人加入追蹤

    立即追蹤

佳醫 (4104) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

佳醫 (4104) 月營收分析比較圖

佳醫 (4104) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/02575,306604,745-25%-4.9%1,342,8751,284,5244.5%
2024/01767,569679,7795.6%12.9%767,569679,77912.9%
2023/12727,021675,492-6.4%7.6%8,232,5137,186,65414.6%
2023/11777,091653,98514.3%18.8%7,505,4926,511,16215.3%
2023/10679,954633,490-3.5%7.3%6,728,4015,857,17714.9%
2023/09705,001643,3961.4%9.6%6,048,4475,223,68715.8%
2023/08695,296634,67212.5%9.6%5,343,4464,580,29116.7%
2023/07617,997562,980-5.4%9.8%4,648,1503,945,61917.8%
2023/06653,531519,919-3.7%25.7%4,030,1533,382,63919.1%
2023/05678,374571,111-0.1%18.8%3,376,6222,862,72018%
2023/04678,780583,365-7.6%16.4%2,698,2482,291,60917.7%
2023/03734,944563,66621.5%30.4%2,019,4681,708,24418.2%
2023/02604,745501,960-11%20.5%1,284,5241,144,57812.2%
2023/01679,779642,6180.6%5.8%679,779642,6185.8%
2022/12675,492607,5663.3%11.2%7,186,6546,573,8059.3%
2022/11653,985598,8573.2%9.2%6,511,1625,966,2399.1%
2022/10633,490580,120-1.5%9.2%5,857,1775,367,3829.1%
2022/09643,396551,4631.4%16.7%5,223,6874,787,2629.1%
2022/08634,672539,83812.7%17.6%4,580,2914,235,7998.1%
2022/07562,980486,1398.3%15.8%3,945,6193,695,9616.8%
2022/06519,919493,203-9%5.4%3,382,6393,209,8225.4%
2022/05571,111556,218-2.1%2.7%2,862,7202,716,6195.4%
2022/04583,365533,1993.5%9.4%2,291,6092,160,4016.1%
2022/03563,666541,86512.3%4%1,708,2441,627,2025%
2022/02501,960532,455-21.9%-5.7%1,144,5781,085,3375.4%
2022/01642,618552,8825.8%16.2%642,618552,88216.2%
2021/12607,566542,9711.5%11.9%6,573,8056,680,927-1.6%
2021/11598,857555,7823.2%7.8%5,966,2396,137,956-2.8%
2021/10580,120577,0135.2%0.5%5,367,3825,582,174-3.8%
2021/09551,463573,9072.2%-3.9%4,787,2625,005,161-4.3%
2021/08539,838569,14411%-5.1%4,235,7994,431,254-4.4%
2021/07486,139542,778-1.4%-10.4%3,695,9613,862,110-4.3%
2021/06493,203507,393-11.3%-2.8%3,209,8223,319,332-3.3%
2021/05556,218534,8504.3%4%2,716,6192,811,939-3.4%
2021/04533,199543,510-1.6%-1.9%2,160,4012,277,089-5.1%
2021/03541,865565,1161.8%-4.1%1,627,2021,733,579-6.1%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音